Next Article in Journal
MicroRNAs in Ocular Infection
Next Article in Special Issue
Volatile Composition and Sensory Properties of Mead
Previous Article in Journal
Identification of Microbial Profiles in Heavy-Metal-Contaminated Soil from Full-Length 16S rRNA Reads Sequenced by a PacBio System
Previous Article in Special Issue
Analysis of Factors Influencing the Transmembrane Voltage Induced in Filamentous Fungi by Pulsed Electric Fields
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Discovery of Relevant Hepatoprotective Effects and Underlying Mechanisms of Dietary Clostridium butyricum Against Corticosterone-Induced Liver Injury in Pekin Ducks

1
College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
2
Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China
*
Author to whom correspondence should be addressed.
Submission received: 5 July 2019 / Revised: 30 August 2019 / Accepted: 12 September 2019 / Published: 16 September 2019
(This article belongs to the Special Issue Recent Advances in Applied Microbiology)

Abstract

:
Clostridium butyricum (C. butyricum) can attenuate oxidative stress, inflammation, and hepatic fatty deposition in poultry, however, the underlying mechanisms for this in Pekin ducks remain unclear. This study evaluated these hepatoprotective effects and the underlying mechanisms in a corticosterone (CORT)-induced liver injury model in Pekin ducks fed a C. butyricum intervention diet. A total of 500 Pekin ducks were randomly divided into five groups: one group (CON group) was only provided with a basal diet, three groups were provided a basal diet with 200 mg/kg (LCB group), 400 mg/kg (MCB group), or 600 mg/kg (HCB group) C. butyricum, respectively, and one group was provided a basal diet with 150 mg/kg aureomycin (ANT group) for 42 d. At 37 days-old, all ducks received daily intraperitoneal injections of CORT for five days to establish a liver injury model. C. butyricum intervention alleviated liver injury by decreasing the liver organ indices, hepatic steatosis and hepatocyte necrosis, and improving liver function, antioxidant capacity, and inflammatory factors. Hepatic RNA-seq revealed 365 differentially expressed genes (DEGs) between the MCB and CON groups, with 229 up- and 136 down-regulated DEGs in the MCB group. Between the MCB and ANT groups, 407 DEGs were identified, including 299 up- and 108 down-regulated genes in MCB group. Some DEGs in the MCB group related to oxidative stress and inflammatory responses such as Sod3, Tlr2a/b, and Il10, which were up-regulated, while Apoa1, Cyp7a1, Acsl1/5, Fasn, Ppar-γ, and Scd, which are involved in lipid metabolism, were down-regulated, indicating that these genes were responsive to dietary C. butyricum for the alleviation of corticosterone-induced hepatic injury. Toll-like receptor signaling, PI3K-Akt signaling pathway, cytokine-cytokine receptor interaction, peroxisome proliferator-activated receptor (PPAR) signaling pathway, adipocytokine and glycerophospholipid metabolism signaling pathway were significantly enriched in the MCB group. These findings indicate that C. butyricum intervention can protect Pekin ducks from corticosterone-induced liver injury by the modulation of immunoregulatory- and lipid metabolism-related genes and pathways.

1. Introduction

The timid nature of Pekin ducks makes them easily stressed. Intensively reared ducks are constantly exposed to various adverse influences, such as noise, crowding, handling, transport, high temperature, and immune challenges, which leads to chronic stress [1,2]. Stress in poultry can activate the hypothalamic pituitary adrenal axis, resulting in increased corticosterone (CORT) secretion [3]. Therefore, the serum CORT level is considered a reliable stress indicator in poultry [4]. Recently, numerous publications have demonstrated that a CORT challenge can reliably induce physiological stress in rodents and birds [5,6]. Additionally, a CORT challenge can also lead to decreased body weight, and can influence lipid metabolism and immune system responses [7,8,9].
The liver plays an important role in maintaining metabolic homeostasis [10]. A fatty liver, oxidative stress, and inflammation are the major mechanisms underlying the pathogenesis of liver injury induced by CORT [8,11,12]. Hepatic inflammation and lipogenesis can be affected by a number of hormones, including glucocorticoids, which modulate metabolic homeostasis and stress responses [13,14]. Glucocorticoids are important regulators of lipid metabolism, and chronic low level exposure to glucocorticoids promotes lipogenesis to produce fatty liver [15,16]. CORT is the primary active form of glucocorticoids and is considered as an induced indicator of fatty liver and stress [17]. Chronic high levels of CORT are closely related to fatty liver progression and inflammatory responses [18]. Exogenous CORT administration to animals can induce abnormal lipid accumulation and an inflammatory response in the liver that can progress to fatty liver diseases [19,20]. However, no relevant studies in Pekin ducks have been reported in the literature.
Clostridium butyricum (C. butyricum), regarded as a beneficial probiotic, exists in the intestinal tract and acts to protect against pathogenic bacteria and intestinal injury [21]. Direct feeding of C. butyricum to different animals (such as broilers, Pekin ducks and shrimps) can enhance growth performance, antioxidant properties, as well as meat quality, and modulate intestinal microflora, balance intestinal health, and regulate the immune system by activating related genes and signaling pathways [22,23,24]. Beyond its beneficial effects in the digestive tract, C. butyricum can protect mice against non-alcoholic fatty liver disease (NAFLD) induced by a high fat diet [25] and the anti-oxidation and anti-inflammation protective effects of C. butyricum have also been demonstrated in previous studies for other diseases [26,27]. Although the probiotic C. butyricum can improve the intestinal health and immune status of weaned piglets challenged with lipopolysaccharide (LPS) [28] and suppress hepatic damage degree in mice challenged with CORT [25], it is largely unknown whether probiotic C. butyricum intervention can attenuate liver injury in Pekin ducks under CORT challenge. Transcriptome analysis is an effective technique to identify the genes that are differentially expressed and signaling pathways that are affected by environmental endocrine disruptors and we have already used transcriptome analysis to demonstrate the effects of dietary C. butyricum on the breast muscle of Pekin ducks [29]. Therefore, it is interesting to use the RNA-sequencing (RNA-seq) method in order to determine the underlying hepatoprotective mechanisms active in Pekin ducks supplemented with dietary C. butyricum under CORT challenge through a combined analysis of lipid metabolism and inflammation response.
In this study, we aimed to investigate whether dietary C. butyricum intervention can alleviate CORT-induced oxidative stress, inflammation, and lipid accumulation in the liver of Pekin ducks, and to explore the underlying mechanisms of these effects using the RNA-sequencing technique. We hope our study can help to solve the stress problems of Pekin duck in the breeding process for the future, and eventually enhance the associated economic income.

2. Materials and Methods

2.1. Ethics Statement

This study was carried out in accordance with the recommendations of Animal Care and Use Ethics Committee of China Agricultural University under protocol code CAU20180428-2. The protocol was approved by the Animal Care and Use Ethics Committee of China Agricultural University (approval date: 28 April 2018).

2.2. Animals and Experimental Design

A total of 500 male Pekin ducks (1-day-old) were selected from a local commercial hatchery (Beijing Golden Star Duck Co., Ltd.) and the experiment was performed at the Experimental Center of China Agricultural University. The birds were randomly assigned into five groups (five replicates with twenty birds each) and were raised in a temperature-controlled room. The temperature was controlled at 32 to 34 °C during the first 5 days, and then subsequently declined (about 2–3 °C/week) to a final temperature of 22 °C. All ducks had free access to feed and drinking water with a 23L: 1D lighting system during the experiment. The control group (CON) was fed with a corn-soybean basic diet for 42 d. The other four groups were fed with the basic diet supplemented with 200 mg/kg (LCB), 400 mg/kg (MCB), or 600 mg/kg (HCB) C. butyricum (2.0 × 109 CFU/g) or 150 mg/kg aureomycin (ANT), respectively (Figure 1). The nutrient requirements of the diets were calculated to meet or exceed the National Research Council (NRC, 1994) standards (Table S1). The C. butyricum is available as a freeze-dried powder obtained from Beijing Shine Biology Technology Co., Ltd., China (Batch No. 20170325003).
At 37-days-old, twelve ducks were randomly selected from each group and challenged with CORT (4 mg/kg, Sigma-Aldrich, Shanghai, China) for 5 days. CORT was premixed in corn oil (1:1) and injected into the abdominal cavity. The dose of 4 mg/kg was demonstrated previously to enhance serum CORT content. Injections were done once daily between 07:00 and 08:00.

2.3. Sample Collection

The body weight of the selected 12 ducks from each group was recorded after feed fasting for 6 h at 37- and 42-days old. On day 42, blood samples (5 mL) were taken from the wing vein for biochemical analysis. Subsequently, all 12 ducks were euthanized by giving sodium pentobarbitone solution (30 mg/kg/BW) intravenously through the leg anesthetic to reduce discomfort. After dissection, the entire liver was weighed to calculate the liver organ indices. All liver samples were frozen in liquid nitrogen immediately and stored at –80 °C until further RNA-seq analysis.

2.4. Histological Examination of Hepatic Tissue

Liver samples were freshly dissected and, after appropriate fixation (10% formaldehyde neutral buffer solution) and paraffin embedding, samples were sectioned at a thickness of 4 μm and stained with hematoxylin and eosin (H&E). Frozen liver sections were made at −18 °C using a Leica kryostat (Leica CM3050S, Leica instrument GmbH, Germany), then stained with Oil Red O (O0625; Sigma-Aldrich Co., St. Louis, MO, USA) for 15 min and counterstained with hematoxylin. The slides were observed using an optical microscope (Olympus BX50 microscope; Olympus Corporation, Tokyo, Japan).

2.5. Measurement of Liver Function Indices

The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyltranspeptidase (γ-GGT) in serum were measured using the assay kits (Nanjing Jiancheng Inc., Nanjing, China) according to the manufacturer’s instructions. The total protein (TP), albumin (ALB), and globulin (GLB) were detected using a Roche Cobas702 automatic biochemical analyzer (Roche, Basel Switzerland).

2.6. Detection of Oxidative Stress and Cytokines

Liver tissues (200 mg) were homogenized in 0.9% physiological saline to obtain a 10% homogenate. The total antioxidant capacity (T-AOC), total superoxide dismutase (T-SOD), and glutathione peroxidase (GSH-PX) activities as well as the reactive oxygen species (ROS) and malondialdehyde (MDA) contents of the 10% homogenate were measured using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The total hepatic protein was detected by the method of Coomassie brilliant blue using the commercial kit (Nanjing Jiancheng Bioengineering Institute, China). The concentrations of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), IL-6, IL-4, IL-10 and transforming growth factor-β (TGF-β) in the liver homogenate were detected using commercial ELISA kits (Nanjing Jiancheng Bioengineering Institute, China). All procedures were performed according to the manufacturer’s instructions. The levels of CORT in serum were determined by the Beijing Huaying Biotechnology Company (Beijing, China) using a radioimmunoassay method.

2.7. RNA Isolation, Library Preparation, and Sequencing

The liver samples of nine randomly selected ducks (three from each of the CON, MCB, and ANT groups) were separately ground for 30 s using the easy grind method in liquid nitrogen. Total RNA was then extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s protocol. RNA quality and purity were determined using a Nano-Drop 2000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) at 260 and 280 nm, and RNA integrity was checked on an Agilent 2100 Bionalyzer (Agilent Technologies, Les Ullis, France) and by 1.2% agarose gel electrophoresis. Only RNA samples with OD260/OD280 ratios between 1.8 and 2.2 and an RNA integrity number (RIN) ≥ 8.0 were selected for cDNA library generation. Next, RNA samples from the nine ducks were then packed in dry ice and sent to Shanghai Majorbio Bio-pharm Technology Co., Ltd. (Shanghai, China) for further library preparation and sequencing. The cDNA library was sequenced using an Illumina HiSeq 4000 (Illumina, San Diego, CA, USA) using paired-end technology.
The quality of raw reads was evaluated using the FastQC program (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Raw reads with a threshold quality < 20, reads shorter than 50 nt, as well as reads containing adapter sequences, poly-N, or the sequencing primer were removed using SeqPrep software (https://github.com/jstjohn/SeqPrep) and Sickle software (https://github.com/najoshi/sickle) to obtain clean reads. Additionally, the quality of the clean data was evaluated according to Error%, Q30, GC content%, average read length and sequence duplication level. The high-quality clean reads were used for subsequent analyses and functional annotation. The high quality clean reads of the nine samples were separately mapped to the reference Anas platyrhynchos genome (http://asia.ensembl.org/Anas_platyrhynchos/Info/Index?db=core) using TopHat2 (version: 2.0.9) [30]. The normalization of gene expression levels was obtained by converting the RNA-seq transcript abundance into fragments per kilobase per million mapped reads (FPKM) [31]. The RNA-seq datasets used and/or analyzed during the study are available in the NCBI Sequence Read Archive (SRA) under the accession number SRP134223.

2.8. Enrichment Analysis of GO Terms and KEGG Pathways for DEGs

The edgeR software (http://www.bioconductor.org/packages/2.12/bioc/html/edgeR.html) was used to identify differentially expressed genes (DEGs) among the three groups and fold change was calculated based on FPKM values. The p values were adjusted by a false discovery rate (FDR) correction method. Genes with a corrected p-value < 0.05 and fold-change ≥ 2 or ≤ 0.5 were considered to be significantly differentially expressed.
Gene ontology (GO) term enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis for the identified DEGs were performed using the free online platform Majorbio I-Sanger Cloud Platform (www.i-sanger.com) to predict the metabolic pathways in which the DEGs are involved. The DEGs of GO term enrichment was classified into the categories of molecular functions, cellular component, and biological process. A corrected p-value < 0.05 indicated significant enrichment. Additionally, a complementary and more comprehensive pathway activation strength (PAS) value analysis of GO processes based on DEGs was performed using OmicsBean (http://www.omicsbean.cn) to further identify the deep biological processes and pathways.

2.9. Confirmation of RNA-seq Data by qRT-PCR

To validate the accuracy of the RNA-seq data, we randomly selected 20 DEGs for qRT-PCR analysis. A total of six RNA samples from each group were reverse transcribed to complementary DNA using a Prime Script RT Master Mix Kit with DNase I (TaKaRa, Dalian, China) following the manufacturer’s instructions. Primers were designed using primer premier 5.0 software and were synthesized by Sangon Biotech Co., Ltd. (Shanghai, China) (Table S2). Then, qRT-PCR was performed in triplicate reactions in 96 well plates using the Top Green qPCR SuperMix Kit (TransGen Biotech, Beijing, China) according to the manufacturer’s instructions using the following cycling conditions: 95 °C for 30 s, followed by 40 cycles of 95 °C for 10 s, and 55 °C for 42 s, then 72 °C for 10 s, followed by 72 °C for 5 min. A melting curve was then produced using an ABI QuantStudio 7 Flex Sequence Detection System (Applied Biosystems Co. Ltd., Foster City, CA, USA). The fold expression change of DEGs was calculated using the 2−ΔΔCt method [32]. The mRNA levels of the DEGs were normalized against an endogenous reference gene, glyceraldehyde-3-phosphate dehydrogenase (Gapdh).

2.10. Statistical Analysis

The results are presented as the mean ± standard deviation (S.D.). The data were determined by one-way ANOVA followed by Duncan’s multiple comparisons between groups using SPSS25.0 software (SPSS, Chicago, IL, USA). p < 0.05 or less was considered statistically significant.

3. Results

3.1. C. butyricum Alleviated Impaired Growth Performance and Liver Organ Indices Induced by CORT

The effects of C. butyricum intervention on body weight (BW) of Pekin ducks were presented in Figure 2. On day 37, before the CORT challenge, the final body weights in LCB, MCB, and ANT groups were significantly (p < 0.05) greater than that in the CON group. On day 42, 5 days after the CORT challenge, the final body weights in LCB, MCB, and ANT groups were still significantly (p < 0.05) greater than that in the CON group. Supplementing ducks with C. butyricum at 600 mg/kg had no impact on body weight either before or after the CORT challenge. The CORT challenge for five days decreased the final body weight of all Pekin ducks, however, C. butyricum intervention could alleviate the decrease of body weight. Additionally, CORT challenge for five days significantly increased the liver organ indices in the CON group, but this increase significantly decreased in the MCB and HCB groups at 42 d (Table 1).

3.2. C. butyricum Alleviated Liver Function Indices Induced by CORT

As shown in Table 2, CORT treatment increased the serum activities of AST and ALT at 42 d (p < 0.05). However, C. butyricum intervention significantly alleviated the CORT-increased levels of AST and ALT (p < 0.05). CORT treatment decreased ALB contents (p < 0.05) while C. butyricum intervention significantly (p < 0.05) prevented this decrease at 42 d. Thus, the probiotic C. butyricum can protect against CORT-induced liver damage.

3.3. C. butyricum Alleviated Pathological Liver Damage Induced by CORT

The histological sections stained with hematoxylin-eosin (H&E) (Figure 3A) and Oil Red O (Figure 3B) both indicated that lipid accumulation severely increased at 42 d after the CORT challenge, but this increase was drastically attenuated in the C. butyricum-supplemented groups and the ANT group. Additionally, hepatic steatosis, lymphocyte aggregation, severe hepatocyte necrosis, and inflammatory cell infiltration especially around the central veins were observed in the CON group liver after CORT challenge. However, these pathological changes were clearly attenuated by C. butyricum intervention, especially in the MCB group. The relieved degree of hepatic steatosis, lymphocyte aggregation and hepatocyte necrosis were presented in the Figure 3C.

3.4. C. butyricum Alleviated Hepatic Oxidative Stress Induced by CORT

The CORT challenge weakened the activities of T-SOD and GSH-PX while it increased ROS and MDA levels in the liver and CORT concentration in serum. However, C. butyricum intervention had the opposite effects, as it significantly enhanced the activities of T-SOD and GSH-PX and reduced the ROS and MDA levels (p < 0.05), especially in MCB and HCB at 42 d. Moreover, the CORT contents in the C. butyricum-intervened groups significantly (p < 0.05) decreased compared to the CON group at 42 d (Table 3).

3.5. C. butyricum Alleviated the Hepatic Inflammation Response Induced by CORT

To investigate whether inflammation could be attenuated by C. butyricum, the levels of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) in liver tissue at 42 d were tested (Table 4). The CORT challenge clearly increased the concentrations of IL-1β, IL-6 and TNF-α in the liver, but these increases were significantly decreased by C. butyricum intervention (p < 0.05). Moreover, we also detected the production of the anti-inflammatory factors IL-4, IL-10, and TGF-β in the liver, and found that they were all reduced by the CORT challenge, but that IL-4 and IL-10 were significantly elevated (p < 0.05) by C. butyricum.

3.6. Quality Control of Liver RNA-seq Data

We established nine cDNA libraries from the livers of ducks at 42 d from the CON, MCB, and ANT groups, with three replicates in each group. Quality control is an essential step to determine the quality of RNA-seq data. RNA-seq generated 56781984-86256452 raw reads for each library (Table 5). Low-quality reads were filtered out, and the average numbers of clean reads were 69861501 (95.70%), 69132671 (97.53%), and 67804130 (97.59%) of the CON, MCB and ANT groups, respectively. We only used the clean reads for downstream analyses. After assembly, an average of 72.77% clean reads from each library was uniquely mapped to the reference duck genome (http://asia.ensembl.org/Anas_platyrhynchos/Info/Index?db=core), and the average mapping ratios were 69.85%, 76.53%, and 71.94% for the CON, MCB and ANT groups, respectively. The error rate, GC (guanine-cytosine) content, Q20 (Phred quality score 20), Q30, and mapping ratio of each samples are listed in Table 6. We concluded that the RNA-seq data was of reliable quality. The mapped reads in different regions of the genome are presented in Figure S1. The 15 most abundantly expressed genes in both MCB and ANT groups, ranked by absolute abundance, were Alb, Ttr, Thrsp, Hpx, Apoa1, Ahsg, Mt1, Eee1a1, Vtn, Fabp1, Ppdpf, Fgg, Aldob, Fgb, and Scd (Table S3). The GO categories and KEGG analysis of functional annotation and classification related to all unigenes are shown in Supplementary Figures S2 and S3. Through the alignment of GO and KEGG databases, the largest number of genes was associated with signal transduction and cellular process.

3.7. Identification of DEGs

The volcano plot of the significantly DEGs was shown in Figure 4A,C. A total of 365 significantly DEGs (229 up-regulated and 136 down-regulated) were identified between the MCB and CON groups (Figure 4B; Supplementary file 1; FDR ≤ 0.05, fold-change ≥ 2 or ≤ 0.5) using edgeR software. The numbers of significantly enriched genes in the terms biological process, cell component, molecular function, and the KEGG pathway were 1146, 65, 100, and 5, respectively (Figure 5A). A total of 407 significantly DEGs (299 up-regulated and 108 down-regulated) were identified between the MCB and ANT groups (Figure 4D; Supplementary file 1; FDR ≤ 0.05, fold-change ≥ 2 or ≤ 0.5) using edgeR software. The numbers of significantly enriched genes in the terms biological process, cell component, molecular function, and the KEGG pathway were 387, 42, 110, and 6, respectively (Figure 5B).

3.8. GO and KEGG Analysis of DEGs in Liver

We used DEGs to further analyze GO and KEGG enrichment in order to determine their potential functions and metabolic pathways. The DEGs between the CON and MCB groups were primarily enriched in the positive regulation of immune system process, T cell differentiation, immune response, leukocyte cell-cell adhesion, immune system process, regulation of immune system process, leukocyte aggregation, lymphocyte activation, T cell activation, alpha-beta T cell activation, and lipid metabolic process in molecular functions (Figure 6A; Supplementary file 2). Therefore, the GO term enrichment analysis showed that the DEGs between the CON and MCB groups were significantly enriched in immunity and lipid metabolism. The DEGs between the MCB and ANT groups were primarily enriched in the regulation of cell differentiation, regulation of developmental process, cell differentiation, single-organism developmental process, developmental process, regulation of multicellular organismal process, cellular lipid metabolic process, and lipid metabolic process in molecular functions (Figure 6B; Supplementary file 2). The GO term enrichment analysis showed that the DEGs between the MCB and ANT groups were significantly enriched in development and metabolism. The primary enriched GO processes of DEGs are shown in Figure 7. Compared with the CON group, providing a moderate amount of C. butyricum to Pekin ducks mainly up-regulated the cellular process, metabolism process, and response to stimulus and down-regulated the biosynthetic process in the liver (Figure 7A). However, the cellular process and metabolism process were up-regulated, and the developmental process involved in reproduction was down-regulated in the MCB group compared with the ANT group (Figure 7B). Therefore, moderate levels of C. butyricum had a protective effect on the CORT-induced liver damage compared with the CON and ANT groups.
In addition, compared with the CON group, C. butyricum dietary supplementation at 400 mg/kg significantly (p < 0.05) activated cell adhesion molecules (CAMs), cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, metabolism of xenobiotics by cytochrome P450, PPAR signaling pathway, glutathione metabolism, and Toll-like receptor signaling pathway in the liver. Dietary supplementation with C. butyricum activated glycerophospholipid metabolism, AMP-activated protein kinase (AMPK) signaling pathway, cytokine-cytokine receptor interaction, PPAR signaling pathway, adipocytokine signaling pathway, and fatty acid biosynthesis in the liver (Table 6; Supplementary file 3). The DEGs enriched in the above pathways are presented in Table 7. Our KEGG pathway enrichment analysis of the DEGs showed that many immunity and lipid metabolism-related pathways were significantly enriched for DEGs in the alleviation of CORT-induced liver damage in Pekin ducks supplemented with C. butyricum.

3.9. Confirmation of Gene Expression with Quantitative RT-PCR

To confirm the accuracy of the RNA-seq transcriptome data, we randomly selected ten genes between the MCB and CON groups and ten genes between the MCB and ANT groups—each ten genes including four significantly up-regulated genes, four significantly down-regulated genes, and two genes with no significant differential expression. The expression levels of the selected genes were quantified using qRT-PCR, and the results were consistent with the transcriptome results (Figure 8). The results suggest that RNA-Seq reliably identified the DEGs in the duck’s liver transcriptome.

4. Discussion

C. butyricum is reported to have a variety of beneficial effects in humans and animals, including promoted growth performance [33], improved meat quality [22], enhanced immune function [34], alleviated oxidative stress [26], attenuated fatty liver disease [25], and balanced intestinal microflora [33]. In our study, C. butyricum supplementation at 200mg/kg (LCB) and 400 mg/kg (MCB) both significantly increased the body weight of Pekin ducks at 37 d before CORT challenge. However, C. butyricum supplementation at 600 mg/kg (HCB) did not significantly affect growth performance compared with the CON group, indicating that 600 mg/kg C. butyricum does not positively promote the growth performance of Pekin ducks. Antibiotic supplementation also had positive effects on Pekin duck’s growth performance. Numerous studies have reported that sub-therapeutic use of antibiotics in diets can promote growth performance and control gastrointestinal bacterial infections in Pekin ducks [35]. However, the use of antibiotics which has largely led to the emergence of resistant bacteria and the potential for producing drug residues in animal feed and products; therefore, a ban has been issued [36]. C. butyricum is, therefore, an alternative to improve the growth performance of animals. Exogenous CORT administration significantly suppresses body weight in ducks [2], which is consistent with the results of our study. In our study, the body weight of ducks at 42 d decreased after CORT challenge, but C. butyricum intervention (especially 400 mg/kg) significantly attenuated this degree. Although the antibiotic presented the same protective effects as C. butyricum, we recommend using C. butyricum instead of antibiotics.
The liver is susceptible to CORT challenges, so it was selected as the research model. To further confirm the protective effects of C. butyricum on hepatic function in Pekin ducks, we measured the serum levels of aminotransferase protein and pathological changes in the liver, which are classical parameters used to evaluate hepatic damage induced by CORT [20]. The serum ALT level is used as a special parameter of hepatotoxic effects, while AST activity is considered a less specific biomarker of liver function. However, the elevated AST and ALT levels induced by CORT were drastically attenuated by C. butyricum intervention, and the 400 mg/kg C. butyricum intervention had the best effects. In addition, C. butyricum intervention significantly alleviated the increase in serum ALB levels in MCB and HCB groups. Histological results showed that hepatic steatosis, lymphocyte aggregation and hepatocyte necrosis induced by CORT were also significantly ameliorated by C. butyricum supplementation and the 400 mg/kg C. butyricum intervention had the best effects. C. butyricum supplementation has been demonstrated to alleviate CCl4-induced liver lesions in mice [25]. Meanwhile, other findings have revealed that C. butyricum can effectively attenuate the neurohistopathological changes in dementia mice [37], indicating that C. butyricum supplementation indeed attenuates CORT-induced liver injury.
Oxidative stress is also an important mechanism of liver injury in animals that can involve increased lipid peroxidation and decreased activities of antioxidant enzymes [38]. Our results revealed that C. butyricum attenuated the increase in hepatic MDA and ROS contents and the decrease in SOD and GSH-PX activities induced by CORT in both MCB and HCB groups, indicating that a certain dose of C. butyricum may ameliorate liver injury via an anti-oxidative mechanism. MDA has long been considered an indicator of oxidative stress, and the excess production of ROS can induce immunosuppression [39], but C. butyricum can enhance the activities of antioxidant enzymes to alleviate oxidative stress in animals. A previous study revealed that C. butyricum supplementation can significantly increase the activities of SOD and CAT, and reduce the MDA level after CCl4-induced liver injury in mice [25]. Oxidative stress plays an important role in the pathogenesis of CORT [40], and therefore, these key indices can be used to evaluate the status of oxidative stress and thus provide insight into identifying the mechanisms underlying the protective effects of C. butyricum.
After a CORT challenge for five days, inflammatory reactions play a crucial role. Inflammatory cytokines, such as IL-1β, IL-6 and TNF-α, are associated with CORT-induced hepatic damage. In agreement with previous reports [23], the pro-inflammatory factors were significantly enhanced after CORT challenge and were alleviated by 400 mg/kg C. butyricum supplementation in our study. Moreover, anti-inflammatory factors (IL-4, IL-10 and TGF-β) that were decreased by CORT stimulation were significantly increased in the 400 mg/kg C. butyricum-treated groups. The anti-inflammatory mechanism in this liver injury model is complicated, but it at least involves the attenuation of pro-inflammatory expression and an increase in the levels of IL-4, IL-10 and TGF-β.
Non-alcoholic fatty liver disease (NAFLD) is the result of hepatic steatosis because of lipid accumulation in the liver. Extensive efforts have been made to elucidate the mechanisms underlying hepatic steatosis, which include hepatic fatty acid uptake, de novo lipogenesis, β-oxidation and export [41,42]. Fatty liver formation in waterfowl appears very similar to human NAFLD, making Pekin ducks a very interesting model to better understand hepatic steatosis [43,44]. Previous publications reported that C. butyricum supplementation alleviated hepatic lipid accumulation by enhancing fatty acid β-oxidation and inhibiting lipogenesis [21,25]. In a recent study, C. butyricum attenuated NAFLD progression in broilers, confirming that C. butyricum can protect hepatocytes against chronic damage [45]. Of greater interest, the Oil red O stain showed that pre-administration of C. butyricum to Pekin ducks receiving CORT significantly inhibited lipid accumulation in the liver and the 400 mg/kg C. butyricum intervention showed the best effects. This result indicated that C. butyricum can effectively prevent CORT-induced hepatic steatosis in Pekin ducks.
We demonstrated that C. butyricum can attenuate CORT-induced oxidative stress, inflammatory responses and hepatic steatosis in Pekin ducks and the 400 mg/kg C. butyricum intervention showed the best effects, however, the alleviated mechanisms involved require further exploration. Recently, Illumina transcriptome profiling, as an efficient, rapid method, has become widely used in stock raising [46]. Our study analyzed the hepatic transcriptome of Pekin ducks with 400 mg/kg C. butyricum intervention in order to explore the genes and pathways involved in the protective effects of C. butyricum against CORT. C. butyricum supplementation at 400 mg/kg activated the NF-κB, and toll-like receptor signaling pathways in the liver, thereby promoting lymphocyte development and differentiation, decreased the expression of genes related to pro-inflammatory responses, and increased the expression of genes related to anti-inflammatory responses (such as Tlr2a, Tlr2b and Il10) and anti-oxidant capacity (Sod3). Furthermore, the high level of Alb expression in both MCB and ANT groups increased the serum ALB levels. These two signaling pathways can regulate inflammatory responses and cytokine secretion [47,48]. PI3K-Akt signaling pathway is involved in inflammation and immune regulation and was also significantly enriched in the liver and the Il10r-β and Il10r-α genes were enriched in the PI3K-Akt signaling pathway in the MCB group. IL-10 can promote T cell differentiation and proliferation and can induce the secretion of anti-inflammation cytokines, such as IL-4, IL-10, interferon (IFN)-γ, and TGF-β in cytotoxic T cells and NK cells [49,50]. Accordingly, dietary C. butyricum supplementation up-regulated the transcription levels of genes involved in cytokine-cytokine receptor interaction (enriched genes: Lifr, Bmpr2, Tnfsf10, Ccl5, Il8, and Pdgfra). Therefore, C. butyricum supplementation can improve the antioxidant capacity and inflammatory responses by enhancing the expression of related genes and the enrichment of related pathways to play a hepatoprotective role in Pekin ducks after CORT challenge.
Oil red O staining showed that a CORT challenge induced severe hepatic steatosis, while C. butyricum supplementation decreased the accumulation of liver fat and alleviated the degree of hepatic steatosis. At the transcriptional level, we found the expression of Acsl1, Acsl5, Cyp7a1, Acaa2 and Pck1 were down-regulated; whereas Fabp7 and Cpt1a were up-regulated in the MCB group. These genes were demonstrated to decrease gluconeogenesis and increase fatty acid β-oxidation, fatty acid transportation and cholesterol metabolism [51,52,53]. These results indicated that C. butyricum supplementation in MCB group can modulate hepatic lipid metabolism-related genes in Pekin ducks to alleviate the hepatic steatosis induced by CORT. According to the KEGG analysis, we found that the PPAR signaling pathway, which is associated with lipid metabolism regulation [54], was activated in the C. butyricum-treated group in Pekin ducks, indicating that providing C. butyricum to Pekin ducks can regulate the expression of lipid metabolism-related genes through activation of the PPAR signaling pathway. In the PPAR signaling pathway, the enriched genes associated with lipid transport promoters (Apoa1) and fatty acid oxidation promoters (Fabp7, Cpt1a, and Cpt2) were up-regulated, whereas peroxisome proliferator activated receptor (Ppar-γ), gluconeogenesis promoter (Pck1), fatty acid transport promoter (Acsl1/5 and Lpl), lipogenesis (Me1 and Scd-1) and cholesterol metabolism (Cyp7a1) were down-regulated in the C. butyricum supplementation group compared with the CON and ANT groups.
KEGG pathway analysis revealed that C. butyricum supplementation activated the glycerophospholipid metabolism signaling pathway and alleviated lipid accumulation, which is consistent with a previous report showing that C. butyricum can reduce lipid accumulation in CCl4-challenged mice [25]. Pla2g3 was observed enriched in glycerophospholipid metabolism. Pla2g3 is the rate-limiting enzyme in glycerophospholipid metabolism [55] and is also involved in signal transduction, immune regulation and the inflammatory response [56,57]. Therefore, C. butyricum supplementation modulated glycerophospholipid metabolism by significantly down-regulating Pla2g3 expression in order to protect the liver from lipid accumulation. Additionally, the adipocytokine signaling pathway also clustered more DEGs (Socs3, Pck1, Acsl5 and Cpt1a) in the MCB and ANT groups, indicating that compared with antibiotics, feeding C. butyricum to ducks may have a more obvious protective effect on alleviating lipid accumulation after CORT challenge. Additionally, C. butyricum treatment significantly modulated the expression of genes related to cholesterol transporter activity (up-regulated Abcg1, down-regulated Cetp and Stard5). Abcg1 can increase the transmembrane transport of sterols and phospholipids [58] and Cetp mainly mediates the selective uptake of high density lipoprotein cholesterol by the liver [59]. Therefore, moderate C. butyricum intervention increased the transport and decreased the deposition of cholesterol in the liver, which may alleviate hepatic steatosis induced by CORT. In summary, we demonstrated that C. butyricum intervention protects Pekin ducks from CORT-induced hepatic steatosis in the liver via the epigenetic modulation of lipogenic and lipophagic genes.

5. Conclusions

Our study demonstrated that 400 mg/kg C. butyricum intervention can improve growth performance, attenuate body weight loss, and decrease liver function, hepatic oxidative stress, inflammatory reaction, and hepatic lipid accumulation induced by CORT in Pekin ducks. Transcriptome analysis showed that immune system process, metabolism process, and immune response related DEGs were enriched in GO term analysis in the liver to alleviate CORT damage. Moreover, 400 mg/kg C. butyricum intervention activated Toll-like receptor signaling pathway (Tlr2a/b), PI3K-Akt signaling pathway (Il10r-α/β), PPARs signaling pathway (Cyp7a1, Acsl1/5 and Ppar-γ), glycerophospholipid metabolism (Pla2g3), and cholesterol transporter activity (Abcg1 and Cetp) in the liver, which can improve immune function, promote fatty acid transportation, modulate cholesterol metabolism, and decrease lipid accumulation and fatty acid synthesis following CORT-induced liver injury. The study provides a theoretical basis for the prospective application of C. butyricum administration prior to stress exposure in Pekin ducks, provides an optimal dose of C. butyricum to select, and indicates that C. butyricum may be a kind of protective material or food for animals in order to alleviate stress factors in the breeding process.

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/2076-2607/7/9/358/s1, Table S1: Ingredients and nutrient levels of the basal diets (air-dry basis), Table S2: Primers information used for qRT-PCR in this study, Table S3: The top-15 genes expressed in both MCB and ANT groups, respectively, Table S4: The data of CORT levels in serum of Pekin ducks at 37 d before CORT, Figure S1: The numbers of exons and introns, Figure S2: The GO annotation of the gross unigenes in the hepatic transcriptome, Figure S3: The KEGG classification of the gross unigenes in the hepatic transcriptome, Supplementary file 1: Detailed information of DEGs, Supplementary file 2: Detailed information of GO enrichment of DEGs, Supplementary file 3: Detailed information of KEGG enrichment of DEGs, Supplementary file 4: The raw data of qRT-PCR, Supplementary file 5: PAS value annotation.

Author Contributions

Conceptualization, Y.L.; Data curation, Y.L., C.L. and L.H.; Formal analysis, L.H.; Investigation, C.L.; Project administration, Y.L. and Z.X.; Software, Y.L. and L.H.; Supervision, Z.X.; Validation, Z.X.; Writing—original draft, Y.L. and C.L.; Writing—review & editing, Y.L. and Z.X.

Funding

This research was supported by the System for Poultry Production Technology, Beijing Innovation Research Team of Modern Agriculture (BAIC04-2019). Funders had no role in the study design, analysis, or writing of this article.

Acknowledgments

We gratefully acknowledge Shanghai Majorbio Bio-pharm Technology Co., Ltd. for their technical support in performing the data analysis. We thank Jeremy Allen for editing the English text of a draft of this manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kim, J.M.; Lim, K.S.; Byun, M.; Lee, K.T.; Yang, Y.R.; Park, M.; Lim, D.; Chai, H.H.; Bang, H.T.; Hwangbo, J.; et al. Identification of the acclimation genes in transcriptomic responses to heat stress of White Pekin duck. Cell. Stress. Chaperon. 2017, 22, 787–797. [Google Scholar] [CrossRef] [PubMed]
  2. Harvey, S.; Merry, B.J.; Phillips, J.G. Influence of stress on the secretion of corticosterone in the duck (Anas platyrhynchos). J. Endocrinol. 1980, 87, 161–171. [Google Scholar] [CrossRef] [PubMed]
  3. Kristien, V.; Bert, D.G.; Geelissen, S.M.E.; Kühn, E.R.; Darras, V.M.; Serge, V.D.G. Corticosterone-induced negative feedback mechanisms within the hypothalamo-pituitary-adrenal axis of the chicken. J. Endocrinol. 2005, 185, 383–391. [Google Scholar]
  4. Luo, J.W.; Zhou, Z.L.; Zhang, H.; Ma, R.S.; Hou, J.F. Bone response of broiler chickens (Gallus gallus domesticus) induced by corticosterone. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2013, 164, 410–416. [Google Scholar] [CrossRef] [PubMed]
  5. Lin, H.; Gao, J.; Song, Z.G.; Jiao, H.C. Corticosterone administration induces oxidative injury in skeletal muscle of broiler chickens. Poult. Sci. 2009, 88, 1044–1051. [Google Scholar] [CrossRef] [PubMed]
  6. Perez-Nievas, B.G.; Garcia-Bueno, B.; Caso, J.R.; Menchen, L.; Leza, J.C. Corticosterone as a marker of susceptibility to oxidative/nitrosative cerebral damage after stress exposure in rats. Psychoneuroendocrinology 2007, 32, 703–711. [Google Scholar] [CrossRef] [PubMed]
  7. Lin, H.; Decuypere, E.; Buyse, J. Oxidative stress induced by corticosterone administration in broiler chickens (Gallus gallus Domest.): 2. Short-term effect. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2004, 139, 745–751. [Google Scholar] [CrossRef] [PubMed]
  8. Mehaisen, G.M.; Eshak, M.G.; Elkaiaty, A.M.; Atta, A.M.; Mashaly, M.M.; Abass, A.O. Comprehensive growth performance, immune function, plasma biochemistry, gene expressions and cell death morphology responses to a daily corticosterone injection course in broiler chickens. PLoS. ONE 2017, 12, e0172684. [Google Scholar] [CrossRef]
  9. Liu, J.; Duan, Y.; Hu, Y.; Sun, L.; Wang, S.; Fu, W.; Ni, Y.; Zhao, R. Exogenous administration of chronic corticosterone affects hepatic cholesterol metabolism in broiler chickens showing long or short tonic immobility. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2016, 191, 53–58. [Google Scholar] [CrossRef]
  10. Rebecca, T. Liver regeneration: From myth to mechanism. Nat. Rev. Mol. Cell. Biol. 2004, 5, 836–847. [Google Scholar]
  11. Timiras, P.S.; Koch, P. Morphological and chemical changes elicited in the liver of the rabbit by cortisone and desoxycorticosterone acetate. Anat. Rec. 1952, 113, 349–363. [Google Scholar] [CrossRef] [PubMed]
  12. Hu, Y.; Sun, Q.; Hu, Y.; Hou, Z.; Zong, Y.; Omer, N.A.; Abobaker, H.; Zhao, R. Corticosterone-Induced Lipogenesis Activation and Lipophagy Inhibition in Chicken Liver Are Alleviated by Maternal Betaine Supplementation. J. Nutr. 2018, 148, 316–325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Harris, S.B.; Gunion, M.W.; Rosenthal, M.J.; Walford, R.L. Serum glucose, glucose tolerance, corticosterone and free fatty acids during aging in energy restricted mice. Mech. Ageing. Dev. 1994, 73, 209–221. [Google Scholar] [CrossRef]
  14. Veerle, B.; Christian, T. The innate immune response during liver inflammation and metabolic disease. Trends. Immunol. 2013, 34, 446–452. [Google Scholar]
  15. Andrews, R.C.; Walker, B.R. Glucocorticoids and insulin resistance: Old hormones, new targets. Clin. Sci. 1999, 96, 513–523. [Google Scholar] [CrossRef] [PubMed]
  16. Giguère, V.; Hollenberg, S.M.; Rosenfeld, M.G.; Evans, R.M. Functional domains of the human glucocorticoid receptor. Cell 1986, 46, 645–652. [Google Scholar] [CrossRef]
  17. Targher, G.; Bertolini, L.; Rodella, S.; Zoppini, G.; Zenari, L.; Falezza, G. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin. Endocrinol. 2006, 64, 337–341. [Google Scholar] [CrossRef]
  18. Cockrem, J.F. Stress, corticosterone responses and avian personalities. J. Ornithol. 2007, 148, 169–178. [Google Scholar] [CrossRef]
  19. Duan, Y.; Fu, W.; Song, W.; Ni, Y.; Zhao, R. Effects of tonic immobility (TI) and corticosterone (CORT) on energy status and protein metabolism in pectoralis major muscle of broiler chickens. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2014, 169, 90–95. [Google Scholar] [CrossRef]
  20. Hu, Y.; Sun, Q.; Liu, J.; Jia, Y.; Cai, D.; Idriss, A.A.; Omer, N.A.; Zhao, R. In ovo injection of betaine alleviates corticosterone-induced fatty liver in chickens through epigenetic modifications. Sci. Rep. 2017, 7, 40251. [Google Scholar] [CrossRef]
  21. Zhang, B.; Yang, X.; Guo, Y.; Long, F. Effects of dietary lipids and Clostridium butyricumon the performance and the digestive tract of broiler chickens. Arch. Anim. Nutr. 2011, 65, 329–339. [Google Scholar] [CrossRef] [PubMed]
  22. Liu, Y.; Li, Y.; Feng, X.; Wang, Z.; Xia, Z. Dietary supplementation with Clostridium butyricum modulates serum lipid metabolism, meat quality, and the amino acid and fatty acid composition of Peking ducks. Poult. Sci. 2018, 97, 3218–3229. [Google Scholar] [CrossRef]
  23. Liao, X.; Wu, R.; Ma, G.; Zhao, L.; Zheng, Z.; Zhang, R. Effects of Clostridium butyricum on antioxidant properties, meat quality and fatty acid composition of broiler birds. Lipids. Health. Dis. 2015, 14, 36. [Google Scholar] [CrossRef] [PubMed]
  24. Duan, Y.; Zhang, Y.; Dong, H.; Wang, Y.; Zheng, X.; Zhang, J. Effect of dietary Clostridium butyricum on growth, intestine health status and resistance to ammonia stress in Pacific white shrimp Litopenaeus vannamei. Fish. Shellfish. Immunol. 2017, 65, 25–33. [Google Scholar] [CrossRef]
  25. Liu, J.; Fu, Y.; Zhang, H.; Wang, J.; Zhu, J.; Wang, Y.; Guo, Y.; Wang, G.; Xu, T.; Chu, M.; et al. The hepatoprotective effect of the probiotic Clostridium butyricum against carbon tetrachloride-induced acute liver damage in mice. Food. Funct. 2017, 8, 4042–4052. [Google Scholar] [CrossRef] [PubMed]
  26. Sun, J.; Ling, Z.; Wang, F.; Chen, W.; Li, H.; Jin, J.; Zhang, H.; Pang, M.; Yu, J.; Liu, J. Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis. Neurosci. Lett. 2016, 613, 30–53. [Google Scholar] [CrossRef] [PubMed]
  27. Kanai, T.; Mikami, Y.; Hayashi, A. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease. J. Gastroenterol. 2015, 50, 1–12. [Google Scholar] [CrossRef] [PubMed]
  28. Chen, L.; Li, S.; Zheng, J.; Li, W.; Jiang, X.; Zhao, X.; Li, J.; Che, L.; Lin, Y.; Xu, S.; et al. Effects of dietary Clostridium butyricum supplementation on growth performance, intestinal development, and immune response of weaned piglets challenged with lipopolysaccharide. J. Anim. Sci. Biotechnol. 2018, 9, 62. [Google Scholar] [CrossRef]
  29. Liu, Y.; Jia, Y.; Liu, C.; Ding, L.; Xia, Z. RNA-Seq transcriptome analysis of breast muscle in Pekin ducks supplemented with the dietary probiotic Clostridium butyricum. BMC Genomics. 2018, 19, 844. [Google Scholar] [CrossRef]
  30. Trapnell, C.; Roberts, A.; Goff, L.; Pertea, G.; Kim, D.; Kelley, D.R.; Pimentel, H.; Salzberg, S.L.; Rinn, J.L.; Pachter, L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7, 562–578. [Google Scholar] [CrossRef] [Green Version]
  31. Mortazavi, A.; Williams, B.A.; Mccue, K.; Schaeffer, L.; Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 2008, 5, 621–628. [Google Scholar] [CrossRef] [PubMed]
  32. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
  33. Zhang, L.; Zhang, L.; Zhan, X.A.; Zeng, X.; Zhou, L.; Cao, G.; Chen, A.G.; Yang, C. Effects of dietary supplementation of probiotic, Clostridium butyricum, on growth performance, immune response, intestinal barrier function, and digestive enzyme activity in broiler chickens challenged with Escherichia coli K88. J. Anim. Sci. Biotechnol. 2016, 7, 1–9. [Google Scholar] [CrossRef] [PubMed]
  34. Sumon, M.S.; Ahmmed, F.; Khushi, S.S.; Ahmmed, M.K.; Rouf, M.A.; Chisty, M.A.H.; Sarower, M.G. Growth performance, digestive enzyme activity and immune response of Macrobrachium rosenbergii fed with probiotic Clostridium butyricum incorporated diets. J. King. Saud. Univ. Sci. 2018, 30, 21–28. [Google Scholar] [CrossRef]
  35. Zhuang, S.; Jiang, F.B.; Jia, Z.X.; Yan, R. Clostridium butyricum can be used as a potential alternative for the antibiotic in Cherry Valley ducks. J. Anim. Plant. Sci. 2015, 25, 1227–1232. [Google Scholar]
  36. Song, Z.F.; Tian, L.S.; Zhang, X.D. Effects of dietary supplementation with Clostridium butyricum on the growth performance and humoral immune response in Miichthys miiuy. J. Zhejiang Univ. Sci. B 2006, 7, 596–602. [Google Scholar] [CrossRef] [PubMed]
  37. Liu, J.; Sun, J.; Wang, F.; Yu, X.; Ling, Z.; Li, H.; Zhang, H.; Jin, J.; Chen, W.; Pang, M.; et al. Neuroprotective Effects of Clostridium butyricum against Vascular Dementia in Mice via Metabolic Butyrate. Biomed. Res. Int. 2015, 2015, 412946. [Google Scholar] [CrossRef]
  38. Li, S.; Tan, H.Y.; Wang, N.; Zhang, Z.J.; Lao, L.; Wong, C.W.; Feng, Y. The Role of Oxidative Stress and Antioxidants in Liver Diseases. Int. J. Mol. Sci. 2015, 16, 26087–26124. [Google Scholar] [CrossRef] [Green Version]
  39. Simon, H.U.; Haj-Yehia, A.; Levi-Schaffer, F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000, 5, 415–418. [Google Scholar] [CrossRef]
  40. Ayesha, Z.; Naheed, B. Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats. Stress 2009, 12, 167–177. [Google Scholar]
  41. Musso, G.; Gambino, R.; Cassader, M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid. Res. 2009, 48, 1–26. [Google Scholar] [CrossRef] [PubMed]
  42. Elisa, F.; Shelby, S.; Samuel, K. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 2010, 51, 679–689. [Google Scholar]
  43. Katrina, R. NAFLD-the next global epidemic. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 621. [Google Scholar]
  44. Osman, R.H.; Dan, S.; Long, L.; Xia, L.; Sun, X.; Yun, Z.; Wang, L.; Rui, Z.; Zhang, Y.; Zhang, J. Expression of mitochondria-related genes is elevated in overfeeding-induced goose fatty liver. Comp. Biochem. Phys. B Biochem. Mol. Biol. 2016, 192, 30–37. [Google Scholar] [CrossRef] [PubMed]
  45. Endo, H.; Niioka, M.; Kobayashi, N.; Tanaka, M.; Watanabe, T. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: New insight into the probiotics for the gut-liver axis. PLoS ONE 2013, 8, e63388. [Google Scholar] [CrossRef] [PubMed]
  46. Sporer, K.R.; Tempelman, R.J.; Ernst, C.W.; Reed, K.M.; Velleman, S.G.; Strasburg, G.M. Transcriptional profiling identifies differentially expressed genes in developing turkey skeletal muscle. BMC Genomics 2011, 12, 143. [Google Scholar] [CrossRef] [PubMed]
  47. Gregory, M.B.; Ruslan, M. Toll-like receptor signaling pathways. Science 2003, 300, 1524–1525. [Google Scholar]
  48. Ruse, M.; Knaus, U.G. New players in TLR-mediated innate immunity. Immunol. Res. 2006, 34, 33–48. [Google Scholar] [CrossRef]
  49. Hayashi, A.; Sato, T.; Kamada, N.; Mikami, Y.; Matsuoka, K.; Hisamatsu, T.; Hibi, T.; Roers, A.; Yagita, H.; Ohteki, T. A Single Strain of Clostridium butyricum Induces Intestinal IL-10-Producing Macrophages to Suppress Acute Experimental Colitis in Mice. Cell. Host. Microbe 2013, 13, 711–722. [Google Scholar] [CrossRef]
  50. Kashiwagi, I.; Morita, R.; Schichita, T.; Komai, K.; Saeki, K.; Matsumoto, M.; Takeda, K.; Nomura, M.; Hayashi, A.; Kanai, T. Smad2 and Smad3 Inversely Regulate TGF-β Autoinduction in Clostridium butyricum-Activated Dendritic Cells. Immunity 2015, 43, 65–79. [Google Scholar] [CrossRef]
  51. Hubacek, J.A.; Dagmar, B. Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering. Mol. Diagn. 2006, 10, 93–100. [Google Scholar] [CrossRef] [PubMed]
  52. Zeng, T.; Zhang, C.L.; Song, F.Y.; Zhao, X.L.; Xie, K.Q. Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-alpha, and CYP2E1. Food. Chem. Toxicol. 2012, 50, 485–491. [Google Scholar] [CrossRef] [PubMed]
  53. Du, X.; Shen, T.; Wang, H.; Qin, X.; Xing, D.; Ye, Q.; Shi, Z.; Fang, Z.; Zhu, Y.; Yang, Y.; et al. Adaptations of hepatic lipid metabolism and mitochondria in dairy cows with mild fatty liver. J. Dairy Sci. 2018, 101, 9544–9558. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Bedoucha, M.; Atzpodien, E.; Boelsterli, U.A. Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J. Hepatol. 2001, 35, 17–23. [Google Scholar] [CrossRef]
  55. Tremblay, B.L.; Cormier, H.; Rudkowska, I.; Lemieux, S.; Couture, P.; Vohl, M.C. Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: A clinical trial. Lipids. Health. Dis. 2015, 14, 1–9. [Google Scholar] [CrossRef] [PubMed]
  56. Martínez-García, A.; Sastre, I.; Recuero, M.; Aldudo, J.; Vilella, E.; Mateo, I.; Sánchez-Juan, P.; Vargas, T.; Carro, E.; Bermejo-Pareja, F. PLA2G3, a gene involved in oxidative stress induced death, is associated with Alzheimer’s disease. J. Alzheimers. Dis. 2010, 22, 1181–1187. [Google Scholar] [CrossRef] [PubMed]
  57. Starkl, P.; Marichal, T.; Galli, S.J. PLA2G3 promotes mast cell maturation and function. Nat. Immunol. 2013, 14, 527–529. [Google Scholar] [CrossRef] [Green Version]
  58. Kennedy, M.A.; Barrera, G.C.; Nakamura, K.; Baldán, Á.; Tarr, P.; Fishbein, M.C.; Frank, J.; Francone, O.L.; Edwards, P.A. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell. Metab. 2005, 1, 121–131. [Google Scholar] [CrossRef] [Green Version]
  59. Brousseau, M.E. Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1057–1064. [Google Scholar] [CrossRef] [Green Version]
Figure 1. The Pekin duck experiment design and the subsequent assays.
Figure 1. The Pekin duck experiment design and the subsequent assays.
Microorganisms 07 00358 g001
Figure 2. Effects of C. butyricum on body weight (BW) of Pekin ducks at 37 d before corticosterone (CORT) challenge and 42 d after CORT challenge for 5 d, respectively. The data were showed as mean ± S.D. A, B, C was used to show the differences among groups at 37 d before CORT challenge and the different superscript capital letter indicated significant difference (p < 0.05) between any two groups at 37 d before CORT challenge. a, b, c, d was used to show the differences among groups at 42 d after CORT challenge for 5 d and the different superscript small letter indicated significant difference (p < 0.05) between any two groups at 42 d after CORT challenge for 5 d.
Figure 2. Effects of C. butyricum on body weight (BW) of Pekin ducks at 37 d before corticosterone (CORT) challenge and 42 d after CORT challenge for 5 d, respectively. The data were showed as mean ± S.D. A, B, C was used to show the differences among groups at 37 d before CORT challenge and the different superscript capital letter indicated significant difference (p < 0.05) between any two groups at 37 d before CORT challenge. a, b, c, d was used to show the differences among groups at 42 d after CORT challenge for 5 d and the different superscript small letter indicated significant difference (p < 0.05) between any two groups at 42 d after CORT challenge for 5 d.
Microorganisms 07 00358 g002
Figure 3. The effects of C. butyricum on histological changes and lipid distribution in the livers of Pekin ducks after CORT challenge. (A) Oil red O staining (1: 100×, 2: 200×, 3: 400×). (B) Hematoxylin-eosin (H&E) staining. (C) The effects of C. butyricum on the protective degree of hepatic stestosis, lymphocyte and hepatocyte necrosis in different groups after CORT challenge.
Figure 3. The effects of C. butyricum on histological changes and lipid distribution in the livers of Pekin ducks after CORT challenge. (A) Oil red O staining (1: 100×, 2: 200×, 3: 400×). (B) Hematoxylin-eosin (H&E) staining. (C) The effects of C. butyricum on the protective degree of hepatic stestosis, lymphocyte and hepatocyte necrosis in different groups after CORT challenge.
Microorganisms 07 00358 g003
Figure 4. The volcano plot and numbers of DEGs. (A) The volcano plot between the MCB and CON groups. (B) The numbers of the DEGs between the MCB and CON groups. (C) The volcano plot between the MCB and ANT groups. (D) The numbers of the DEGs between the MCB and ANT groups. (A,C): Red dots (Up) represent significantly up-regulated genes (p < 0.05, fold change ≥ 2); blue dots (Down) represent significantly down-regulated genes (p < 0.05, fold change ≤ 0.5); black dots (No) represent insignificantly DEGs. (B,D): The first two columns represent the total number of up-regulated genes (p < 0.05 and p ≥ 0.05, fold change ≥ 2) or down-regulated genes (p < 0.05 and p ≥ 0.05, fold change ≤ 0.5), respectively; the second two columns represent the number of up-regulated genes (p < 0.05, fold change ≥ 2) or down-regulated genes (p < 0.05, fold change ≤ 0.5), respectively.
Figure 4. The volcano plot and numbers of DEGs. (A) The volcano plot between the MCB and CON groups. (B) The numbers of the DEGs between the MCB and CON groups. (C) The volcano plot between the MCB and ANT groups. (D) The numbers of the DEGs between the MCB and ANT groups. (A,C): Red dots (Up) represent significantly up-regulated genes (p < 0.05, fold change ≥ 2); blue dots (Down) represent significantly down-regulated genes (p < 0.05, fold change ≤ 0.5); black dots (No) represent insignificantly DEGs. (B,D): The first two columns represent the total number of up-regulated genes (p < 0.05 and p ≥ 0.05, fold change ≥ 2) or down-regulated genes (p < 0.05 and p ≥ 0.05, fold change ≤ 0.5), respectively; the second two columns represent the number of up-regulated genes (p < 0.05, fold change ≥ 2) or down-regulated genes (p < 0.05, fold change ≤ 0.5), respectively.
Microorganisms 07 00358 g004
Figure 5. Biological process, cellular component, molecular function and KEGG pathway are the four enrichment categories that were used for the functional analysis of DEGs from the MCB vs. CON groups (A) and the MCB vs. ANT groups (B), respectively. Blue bars: Counts for each category represent the total associated terms in the database with the query gene/protein list. Orange bars: Terms with p-value < 0.05 is statistically significant.
Figure 5. Biological process, cellular component, molecular function and KEGG pathway are the four enrichment categories that were used for the functional analysis of DEGs from the MCB vs. CON groups (A) and the MCB vs. ANT groups (B), respectively. Blue bars: Counts for each category represent the total associated terms in the database with the query gene/protein list. Orange bars: Terms with p-value < 0.05 is statistically significant.
Microorganisms 07 00358 g005
Figure 6. The top ten enriched terms of DEGs in each main category (Biologic Process, Cell Component, and Molecular Function) of the GO database. The right y-axis represents the number of genes involved in each GO annotation, and the left y-axis represents the percent of annotated genes in each term to the total number of DEGs. (A) Enriched terms based on DEGs between the MCB and CON groups. (B) Enriched terms based on DEGs between the MCB and ANT groups.
Figure 6. The top ten enriched terms of DEGs in each main category (Biologic Process, Cell Component, and Molecular Function) of the GO database. The right y-axis represents the number of genes involved in each GO annotation, and the left y-axis represents the percent of annotated genes in each term to the total number of DEGs. (A) Enriched terms based on DEGs between the MCB and CON groups. (B) Enriched terms based on DEGs between the MCB and ANT groups.
Microorganisms 07 00358 g006
Figure 7. PAS value of primary enriched GO processes of DEGs using the OmicsBean system. (A) Based on the DEGs between the MCB and CON groups. (B) Based on the DEGs between the MCB and CON groups. Differentially enriched GO processes were identified according to their reporter score from the Z-score of individual genes. A reporter score of Z = 1.96 or Z = −1.96 was used as a detection threshold for significantly different processes.
Figure 7. PAS value of primary enriched GO processes of DEGs using the OmicsBean system. (A) Based on the DEGs between the MCB and CON groups. (B) Based on the DEGs between the MCB and CON groups. Differentially enriched GO processes were identified according to their reporter score from the Z-score of individual genes. A reporter score of Z = 1.96 or Z = −1.96 was used as a detection threshold for significantly different processes.
Microorganisms 07 00358 g007
Figure 8. Validation of DEGs by qRT-PCR. Gapdh was used as an internal control, and data are presented as fold change (N = 6 per group). (A) The DEGs between the MCB and CON groups. (B) The DEGs between the MCB and ANT groups.
Figure 8. Validation of DEGs by qRT-PCR. Gapdh was used as an internal control, and data are presented as fold change (N = 6 per group). (A) The DEGs between the MCB and CON groups. (B) The DEGs between the MCB and ANT groups.
Microorganisms 07 00358 g008
Table 1. Effect of C. butyricum on the liver index of Pekin ducks at 42 d 1.
Table 1. Effect of C. butyricum on the liver index of Pekin ducks at 42 d 1.
ParametersCONLCBMCBHCBANTp Value
Liver index 2 (%)5.91 ± 0.025.84 ± 0.065.76 ± 0.07 *5.74 ± 0.02 *5.87 ± 0.030.003
1 Means ± S.D. (N = 12) with superscript * indicates that there are significant differences (p < 0.05) compared with the control group. 2 liver index = liver weight/body weight.
Table 2. The activities of liver function indexes of Pekin ducks at 42 d 1.
Table 2. The activities of liver function indexes of Pekin ducks at 42 d 1.
Parameters 2CONLCBMCBHCBANTp Value
AST (U/L)43.82 ± 28.5716.63 ± 4.23 *6.65 ± 2.39 *25.76 ± 21.0533.65 ± 16.380.012
ALT (U/L)72.85 ± 42.7238.08 ± 13.2713.17 ± 3.98 *47.25 ± 18.66 *52.35 ± 9.280.002
γ-GGT (U/L)7.39 ± 6.675.84 ± 1.692.03 ± 0.803.40 ± 1.773.57 ± 0.760.056
TP (g/L)32.33 ± 15.0430.87 ± 10.8916.29 ± 3.2031.67 ± 19.5232.43 ± 5.690.142
ALB (g/L)7.40 ± 1.349.73 ± 2.497.24 ± 0.9110.20 ± 1.88 *10.82 ± 1.90 *0.004
GLB (g/L)24.93 ± 15.1221.14 ± 8.469.05 ± 3.6921.48 ± 18.0921.62 ± 3.910.179
1 Means ± S.D. (N = 12) with superscript * indicates that there are significant differences (p < 0.05) compared with the control group in the same row. 2 AST: glutamic oxalacetic transaminase; ALT: alanine transaminase; γ-GGT: glutamyltransferase; TP: total protein; ALB: albumin; GLB: globulin.
Table 3. The oxidative stress levels of Pekin ducks at 42 d of age 1.
Table 3. The oxidative stress levels of Pekin ducks at 42 d of age 1.
Parameters 2CONLCBMCBHCBANTp Value
T-AOC (U/mg prot)10.43 ± 1.3311.72 ± 0.7812.64 ± 2.8711.44 ± 2.7114.41 ± 3.950.124
T-SOD (U/mg prot)92.12 ± 4.07131.23 ± 10.46 *161.47 ± 22.51 *153.97 ± 10.13 *175.30 ± 13.47 *<0.001
GSH-PX (U/mg prot)929.85 ± 73.951085.28 ± 189.531347.49 ± 97.56 *1521.46 ± 50.95 *1377.67 ± 335.80 *<0.001
MDA (U/mg prot)8.59 ± 0.672.28 ± 0.35 *2.03 ± 0.44 *3.12 ± 0.32 *2.54 ± 0.36 *<0.001
ROS (F/mL)672.52 ± 23.69522.26 ± 22.17 *485.18 ± 47.44 *567.18 ± 59.25 *431.78 ± 16.11 *<0.001
CORT (ng/mL)11.75 ± 4.218.88 ± 1.176.69 ± 2.11 *7.99 ± 1.14 *7.25 ± 2.900.013
1 Means ± S.D. (N = 12) with superscript * indicates that there are significant differences (p < 0.05) compared with the control group in the same row. 2 T-AOC: total antioxidant capacity; T-SOD: total superoxide dismutase; GSH-PX: glutathione peroxidase; MDA: malonaldehyde; ROS: reactive oxygen species; CORT: corticosterone.
Table 4. Effect of C. butyricum on inflammation in the liver of Pekin ducks at 42 d 1.
Table 4. Effect of C. butyricum on inflammation in the liver of Pekin ducks at 42 d 1.
Parameters 2 (pg/mg prot)CONLCBMCBHCBANTp Value
IL-1β 30.07 ± 13.7826.24 ± 2.1826.26 ± 9.4228.09 ± 9.2032.41 ± 7.330.738
IL-617.42 ± 2.3016.67 ± 4.4712.99 ± 2.04 *14.19 ± 1.9522.25 ± 2.85 *0.005
TNF-α70.09 ± 2.5249.71 ± 6.54 *69.96 ± 5.6963.40 ± 16.7965.61 ± 11.560.025
IL-429.50 ± 3.5826.25 ± 3.4636.05 ± 6.10 *34.38 ± 6.4228.12 ± 2.11<0.001
IL-1078.82 ± 8.1285.49 ± 3.83134.80 ± 16.86 *123.09 ± 7.24 *73.02 ± 4.72<0.001
TGF-β112.23 ± 12.69142.57 ± 33.09152.11 ± 8.13138.18 ± 31.61131.95 ± 20.550.130
1 Means ± S.D. (N = 12) with superscript * indicates that there are significant differences (p < 0.05) compared with the control group in the same row. 2 TNF-α: tumor necrosis factor-α; TGF-β: transforming growth factor-β.
Table 5. RNA-seq data of the nine liver samples used in this experiment 1.
Table 5. RNA-seq data of the nine liver samples used in this experiment 1.
SampleRaw ReadsClean ReadsError Rate (%)Q20 (%)Q30 (%)GC Content (%)Mapped ReadsMapping Ratio (%)
CON169574378661182880.01497.5593.1053.094476230367.70
CON286256452819862160.01497.5593.1053.045745890470.08
CON363166500614800000.01597.2891.6152.094412539271.77
MCB173128306712832260.01597.3991.8651.895473663976.79
MCB270861430690142760.01597.3691.8351.465307739676.91
MCB368653432671005120.01497.4892.0851.875092475875.89
ANT156781984549566040.01697.1691.2851.424141807075.37
ANT268298598667252880.01597.3991.8652.784789711471.78
ANT383351864817304980.01497.5692.3052.895612777268.67
1 GC, guanine-cytosine; Q20, Phred quality score 20; Q30, Phred quality score 30; Mapping ratio, mapped reads/all clean reads.
Table 6. Enriched KEGG pathways analysis in MCB vs CON and MCB vs ANT.
Table 6. Enriched KEGG pathways analysis in MCB vs CON and MCB vs ANT.
KEGG PathwayGene Countsp Value
MCB vs CON
Cell adhesion molecules (CAMs)80.0025
Cytokine-cytokine receptor interaction50.0242
PI3K-Akt signaling pathway50.0012
Metabolism of xenobiotics by cytochrome P45040.0031
PPAR signaling pathway40.0219
Glutathione metabolism30.0340
Toll-like receptor signaling pathway30.0238
MCB vs ANT
Glycerophospholipid metabolism80.0003
AMPK signaling pathway60.0115
Cytokine-cytokine receptor interaction60.0121
PI3K-Akt signaling pathway60.0540
PPAR signaling pathway50.0042
Adipocytokine signaling pathway40.0135
Glycerolipid metabolism40.0320
NF-kappa B signaling pathway30.0202
Fatty acid biosynthesis20.0127
Table 7. Significantly enriched pathways for differential expressed genes.
Table 7. Significantly enriched pathways for differential expressed genes.
Pathway DescriptionEnriched GenesP Value
MCB vs CON
Cell adhesion molecules (CAMs)Itga6, Tead4, Mpzl1, Cd2, Ptprf, Cd226, Alcam, Loc4807880.0025
PI3K-Akt signaling pathwayRpl35, Ccnd2, Il10r-β, Il10r-α, Csf2ra0.0096
PPAR signaling pathwayApoa1, Fabp1, Cyp7a1, Lpl, Me10.0219
Complement and coagulation cascadesMbl2, C6, C9, Cr10.0310
MCB vs ANT
Glycerophospholipid metabolismGpat, Lpin1, Gnpat, Pla3g3, Lpgat1, Agpat3, Lcat, Agpat20.0003
AMPK signaling pathwayFas, Pck1, Pparg, Cpt1a, Ccna2, Hmgcr0.0115
Cytokine-cytokine receptor interactionLifr, Bmpr2, Tnfsf10, Ccl5, Il8, Pdgfra0.0121
PPAR signaling pathwayFabp7, Acsl5, Pck1, Pparg, Cpt1a0.0042
Adipocytokine signaling pathwaySocs3, Pck1, Acsl5, Cpt1a0.0135

Share and Cite

MDPI and ACS Style

Liu, Y.; Liu, C.; Huang, L.; Xia, Z. A Discovery of Relevant Hepatoprotective Effects and Underlying Mechanisms of Dietary Clostridium butyricum Against Corticosterone-Induced Liver Injury in Pekin Ducks. Microorganisms 2019, 7, 358. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms7090358

AMA Style

Liu Y, Liu C, Huang L, Xia Z. A Discovery of Relevant Hepatoprotective Effects and Underlying Mechanisms of Dietary Clostridium butyricum Against Corticosterone-Induced Liver Injury in Pekin Ducks. Microorganisms. 2019; 7(9):358. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms7090358

Chicago/Turabian Style

Liu, Yanhan, Cun Liu, Liqing Huang, and Zhaofei Xia. 2019. "A Discovery of Relevant Hepatoprotective Effects and Underlying Mechanisms of Dietary Clostridium butyricum Against Corticosterone-Induced Liver Injury in Pekin Ducks" Microorganisms 7, no. 9: 358. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms7090358

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop